🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

160 results for “Vertex” Clear

  1. VX-828

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 1 small molecule active

    2 trials

  2. VX-840

    Vertex Pharmaceuticals (Ireland) Limited

    APOL1-mediated Kidney Disease

    phase 1 small molecule completed

    1 trial

  3. VX-973

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    2 trials

  4. VX-985 or matching placebo

    Vertex Pharmaceuticals (Ireland) Limited

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  5. VX-993

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    phase 1 small molecule completed

    6 trials

  6. Vanzacaftor

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 1 small molecule completed

    1 trial

  7. lumacaftor 200 mg q12h + ivacaftor 250 mg q12h

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  8. telaprevir (VX-950)

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatic Insufficiency

    phase 1 small molecule completed

    1 trial

  9. telaprevir formulation A

    Vertex Pharmaceuticals (Ireland) Limited

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  10. LUM/IVA

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    approved small molecule completed

    8 trials

  11. Suzetrigine

    Vertex Pharmaceuticals (Ireland) Limited

    Pain

    approved small molecule active

    6 trials

  12. Suzetrigine

    Vertex Pharmaceuticals (Ireland) Limited

    Acute Pain

    approved small molecule completed

    2 trials

  13. Telaprevir

    Vertex Pharmaceuticals (Ireland) Limited

    Hepatitis C

    approved small molecule completed

    11 trials

  14. suzetrigine

    Vertex Pharmaceuticals (Ireland) Limited

    Pain, Acute Postoperative

    approved small molecule active

    1 trial

  15. AVN944

    Vertex Pharmaceuticals (Ireland) Limited

    Refractory Solid Tumors

    small molecule terminated

    1 trial

  16. Standard OGTT

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources